Recombinant poxvirus based vaccine against SARS-cov-2 virus
MYPI2026004802A0Undetermined Publication Date: 2021-08-26THE GOVERNORS OF THE UNIV OF ALBERTA +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2026004802
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-11-16
- Filing Date
- 2021-02-26
- Publication Date
- 2021-08-26
Abstract
The invention relates in various aspects to a recombinant poxvirus comprising a nucleic acid encoding a SARS-CoV-2 virus protein, methods for producing such viruses and the use of such viruses. The recombinant poxviruses are well suited, among others, as protective virus vaccines against SARS-CoV-2 virus. FIGURE 4
Need to check novelty before this filing date? Find Prior Art
